Citation Impact

Citing Papers

Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1
2016
Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer
2011
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
Colorectal cancer statistics, 2023
2023 Standout
A survey of best practices for RNA-seq data analysis
2016 Standout
Learning endometriosis phenotypes from patient-generated data
2020
Food-grade TiO2 impairs intestinal and systemic immune homeostasis, initiates preneoplastic lesions and promotes aberrant crypt development in the rat colon
2017 Standout
Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
2019 Standout
DNA methylation age of human tissues and cell types
2013 Standout
Deep learning based tissue analysis predicts outcome in colorectal cancer
2018
Hyperprogression and Immunotherapy: Fact, Fiction, or Alternative Fact?
2020
Cancer treatment and survivorship statistics, 2022
2022 Standout
Molecular Subtypes of Colorectal Cancer and Their Clinicopathologic Features, With an Emphasis on the Serrated Neoplasia Pathway
2016
Feasibility of large-scale deployment of multiple wearable sensors in Parkinson's disease
2017
Myeloid-derived suppressor cells coming of age
2018 Standout
Regulation of microRNA function in animals
2018 Standout
Parkinson's disease
2021 Standout
Microsatellite Instability in Colorectal Cancer
2010 Standout
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination
2015 StandoutNobel
Wearable biosensors for healthcare monitoring
2019 Standout
Biology of colorectal cancer
2015
Chronic inflammation in the etiology of disease across the life span
2019 Standout
StringTie enables improved reconstruction of a transcriptome from RNA-seq reads
2015 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
2018 Standout
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
2019 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
AI in health and medicine
2022 Standout
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
2016 Standout
Inflammaging: a new immune–metabolic viewpoint for age-related diseases
2018 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
Colorectal cancer
2013 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Colorectal cancer
2019 Standout
Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer
2015
Body composition and sarcopenia: The next-generation of personalized oncology and pharmacology?
2018
Vaccine adjuvants – understanding molecular mechanisms to improve vaccines
2014 StandoutNobel
Emerging cytokine networks in colorectal cancer
2015
Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology
2017 Standout
Deep learning in histopathology: the path to the clinic
2021 Standout
Genome-wide Methylation Profiles Reveal Quantitative Views of Human Aging Rates
2012 Standout
Prognostic Value ofBRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer
2016
Screening of Parkinsonian subtle fine-motor impairment from touchscreen typing via deep learning
2020
Idiopathic pulmonary fibrosis
2017 Standout
Sarcopenia
2019 Standout
Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?
2017
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
2012 Standout
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Biospecimens, biomarkers, and burgeoning data: the imperative for more rigorous research standards
2012
DNA methylation-based biomarkers and the epigenetic clock theory of ageing
2018 Standout
Applications of machine learning in drug discovery and development
2019 Standout
Systematic review of agents for the management of gastrointestinal mucositis in cancer patients
2012
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Variability in the immune system: of vaccine responses and immune states
2013
End-to-end design of wearable sensors
2022 Standout
Gene set enrichment analysis of RNA-Seq data: integrating differential expression and splicing
2013
iReckon: Simultaneous isoform discovery and abundance estimation from RNA-seq data
2012
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Associations Between Molecular Classifications of Colorectal Cancer and Patient Survival: A Systematic Review
2018
Hyperprogressive disease: recognizing a novel pattern to improve patient management
2018
Calculating Sample Size Estimates for RNA Sequencing Data
2013
Quadruple Decision Making for Parkinson’s Disease Patients: Combining Expert Opinion, Patient Preferences, Scientific Evidence, and Big Data Approaches to Reach Precision Medicine
2019
Regulatory T Cells and Human Disease
2020 StandoutNobel
Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays
2014 Standout
Targeting Treg cells in cancer immunotherapy
2019 StandoutNobel
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
2014 Standout
The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences
2021 Standout
Clinical Activity of mTOR Inhibition With Sirolimus in Malignant Perivascular Epithelioid Cell Tumors: Targeting the Pathogenic Activation of mTORC1 in Tumors
2010
Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update
2017 Standout
Precision Medicine in Parkinson’s Disease – Exploring Patient-Initiated Self-Tracking
2018
Overtreatment of Young Adults With Colon Cancer
2015
Hyperprogressive disease in early‐phase immunotherapy trials: Clinical predictors and association with immune‐related toxicities
2019
Occurrence and significance of tumor‐associated neutrophils in patients with colorectal cancer
2016
Smartwatch inertial sensors continuously monitor real-world motor fluctuations in Parkinson’s disease
2021
Changing Face of Vaccination in Immunocompromised Hosts
2014
A meta-analysis of MSI frequency and race in colorectal cancer
2016
Advanced Materials for Health Monitoring with Skin‐Based Wearable Devices
2017
Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
2015
Global microRNA level regulation of EGFR‐driven cell‐cycle protein network in breast cancer
2012
Toward a Sample Metadata Standard in Public Proteomics Repositories
2020
Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer
2017
Adjuvant Chemotherapy for Stage II Colon Cancer: A Clinical Dilemma
2017
Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy
2020 StandoutNobel

Works of Brian M. Bot being referenced

Impact of Bioinformatic Procedures in the Development and Translation of High-Throughput Molecular Classifiers in Oncology
2013
Tumor Growth Rate Is an Early Indicator of Antitumor Drug Activity in Phase I Clinical Trials
2013
Developing predictive molecular maps of human disease through community-based modeling
2012
Technical and biological variance structure in mRNA-Seq data: life in the real world
2012
The Mole Mapper Study, mobile phone skin imaging and melanoma risk data collected using ResearchKit
2017
A large dataset of protein dynamics in the mammalian heart proteome
2016
Phase I North Central Cancer Treatment Group Trial-N9923 of escalating doses of twice-daily thoracic radiation therapy with amifostine and with alternating chemotherapy in limited stage small-cell lung cancer
2007
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study
2017
The mPower study, Parkinson disease mobile data collected using ResearchKit
2016
Molecular Markers Identify Subtypes of Stage III Colon Cancer Associated With Patient Outcomes
2014
Formative Evaluation of Participant Experience With Mobile eConsent in the App-Mediated Parkinson mPower Study: A Mixed Methods Study
2017
Genome-Wide Characterization of Transcriptional Patterns in High and Low Antibody Responders to Rubella Vaccination
2013
Integrated Analysis of Gene Expression, CpG Island Methylation, and Gene Copy Number in Breast Cancer Cells by Deep Sequencing
2011
A multicenter phase 2 consortium (P2C) study of the mTOR inhibitor CCI-779 in advanced soft tissue sarcomas (STS)
2006
Mobile health: the power of wearables, sensors, and apps to transform clinical trials
2016
Comparison of Outcomes After Fluorouracil-Based Adjuvant Therapy for Stages II and III Colon Cancer Between 1978 to 1995 and 1996 to 2007: Evidence of Stage Migration From the ACCENT Database
2013
Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on Outcomes in Nine First-Line Treatment Trials Using Individual Data From Patients With Metastatic Colorectal Cancer
2009
Association Between Disease-Free Survival and Overall Survival When Survival Is Prolonged After Recurrence in Patients Receiving Cytotoxic Adjuvant Therapy for Colon Cancer: Simulations Based on the 20,800 Patient ACCENT Data Set
2009
Impact of Young Age on Treatment Efficacy and Safety in Advanced Colorectal Cancer: A Pooled Analysis of Patients From Nine First-Line Phase III Chemotherapy Trials
2011
Rankless by CCL
2026